RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-5.25%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$7.1B
AUM Growth
+$7.1B
(-14%)
Cap. Flow
-$264M
Cap. Flow
% of AUM
-3.72%
Top 10 Holdings %
Top 10 Hldgs %
41.94%
Holding
104
New
17
Increased
24
Reduced
34
Closed
18
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$136M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$130M |
| 3 |
Medtronic
MDT
|
$116M |
| 4 |
LivaNova
LIVN
|
$82.6M |
| 5 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$80M |
Top Sells
| 1 |
AbbVie
ABBV
|
$149M |
| 2 |
Gilead Sciences
GILD
|
$133M |
| 3 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$107M |
| 4 |
Beam Therapeutics
BEAM
|
$99.7M |
| 5 |
Sanofi
SNY
|
$96.4M |
Sector Composition
| 1 | Healthcare | 95.05% |
| 2 | Financials | 0.83% |
| 3 | Consumer Staples | 0.3% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$120M
| $1.07B | 15.05% | 12,957,222 +327,485 | +3% | +$27M |
|
|
ALLK
2
DELISTED
Allakos
ALLK
| $278M | 3.91% | 2,419,418 -248,033 | -9% | -$28.5M |
|
|
IGMS
3
DELISTED
IGM Biosciences
IGMS
| $263M | 3.7% | 3,425,455 | – | – |
|
4
argenx
ARGX
$43.6B
| $234M | 3.3% | 849,845 -68,462 | -7% | -$18.9M |
|
5
Amicus Therapeutics
FOLD
$2.34B
| $209M | 2.94% | 21,114,114 +493,624 | +2% | +$4.88M |
|
|
6
Beam Therapeutics
BEAM
$1.66B
| $203M | 2.86% | 2,532,523 -1,245,739 | -33% | -$99.7M |
|
|
DCPH
7
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $195M | 2.75% | 4,351,644 -86,324 | -2% | -$3.87M |
|
|
NVTA
8
DELISTED
Invitae Corporation
NVTA
| $185M | 2.61% | 4,852,163 -411,146 | -8% | -$15.7M |
|
9
ADC Therapeutics
ADCT
$345M
| $178M | 2.51% | 7,308,418 +549,624 | +8% | +$13.4M |
|
10
Shattuck Labs
STTK
$47M
| $164M | 2.31% | 5,619,914 | – | – |
|
|
MDVL
11
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $164M | 2.31% | 11,724,726 | – | – |
|
|
OSH
12
DELISTED
Oak Street Health, Inc.
OSH
| $159M | 2.24% | 2,930,411 +4,700 | +0.2% | +$255K |
|
13
Krystal Biotech
KRYS
$4.27B
| $159M | 2.24% | 2,060,132 +385,096 | +23% | +$29.7M |
|
|
14
Jazz Pharmaceuticals
JAZZ
$7.75B
| $136M | 1.92% | +829,159 | New | +$136M |
|
|
SGEN
15
DELISTED
Seagen Inc. Common Stock
SGEN
| $130M | 1.83% | +937,045 | New | +$130M |
|
16
Pliant Therapeutics
PLRX
$101M
| $126M | 1.78% | 3,207,193 -181,183 | -5% | -$7.13M |
|
17
Replimune Group
REPL
$422M
| $126M | 1.77% | 4,118,212 +124,813 | +3% | +$3.81M |
|
|
18
Medtronic
MDT
$119B
| $116M | 1.63% | +979,108 | New | +$116M |
|
19
Scholar Rock
SRRK
$3.14B
| $110M | 1.55% | 2,176,628 -719,961 | -25% | -$36.5M |
|
20
Nurix Therapeutics
NRIX
$714M
| $103M | 1.45% | 3,314,117 +467,992 | +16% | +$14.5M |
|
21
Kymera Therapeutics
KYMR
$2.95B
| $101M | 1.42% | 2,603,139 -117,350 | -4% | -$4.56M |
|
22
Atara Biotherapeutics
ATRA
$84.6M
| $98.9M | 1.39% | 6,885,233 +22,163 | +0.3% | +$318K |
|
23
Stoke Therapeutics
STOK
$1.08B
| $98.8M | 1.39% | 2,544,062 -142,172 | -5% | -$5.52M |
|
24
Zentalis Pharmaceuticals
ZNTL
$122M
| $96.4M | 1.36% | 2,221,044 -195,362 | -8% | -$8.48M |
|
25
Annexon
ANNX
$226M
| $96.3M | 1.36% | 3,458,830 +10,800 | +0.3% | +$301K |
|